APA (7th ed.) Citation

Lund, L. H., Crespo‐Leiro, M. G., Laroche, C., Zaliaduonyte, D., Saad, A. M., Fonseca, C., . . . Filippatos, G. (2024). Heart failure in Europe: Guideline‐directed medical therapy use and decision making in chronic and acute, pre‐existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry. European Journal of Heart Failure, 26(12), 2487. https://doi.org/10.1002/ejhf.3445

Chicago Style (17th ed.) Citation

Lund, Lars H., et al. "Heart Failure in Europe: Guideline‐directed Medical Therapy Use and Decision Making in Chronic and Acute, Pre‐existing and De Novo, Heart Failure with Reduced, Mildly Reduced, and Preserved Ejection Fraction – the ESC EORP Heart Failure III Registry." European Journal of Heart Failure 26, no. 12 (2024): 2487. https://doi.org/10.1002/ejhf.3445.

MLA (9th ed.) Citation

Lund, Lars H., et al. "Heart Failure in Europe: Guideline‐directed Medical Therapy Use and Decision Making in Chronic and Acute, Pre‐existing and De Novo, Heart Failure with Reduced, Mildly Reduced, and Preserved Ejection Fraction – the ESC EORP Heart Failure III Registry." European Journal of Heart Failure, vol. 26, no. 12, 2024, p. 2487, https://doi.org/10.1002/ejhf.3445.